Andrew Rezvani

Andrew Rezvani

UNVERIFIED PROFILE

Are you Andrew Rezvani?   Register this Author

Register author
Andrew Rezvani

Andrew Rezvani

Publications by authors named "Andrew Rezvani"

Are you Andrew Rezvani?   Register this Author

36Publications

767Reads

7Profile Views

Costs and Outcomes with Once-Daily versus Every-6-Hour Intravenous Busulfan in Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Sep 13. Epub 2019 Sep 13.

Stanford Hospital and Clinics, Stanford, California; Department of Medicine, Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.008DOI Listing
September 2019

Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat.

Clin Infect Dis 2019 Jul 11. Epub 2019 Jul 11.

Division of Infectious Diseases & Geographic Medicine, Department of Medicine, Stanford University Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz592DOI Listing
July 2019

Acute Graft-versus-Host Disease.

Authors:
Andrew R Rezvani

N Engl J Med 2018 02;378(6):585-586

Stanford University, Stanford, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1716969DOI Listing
February 2018

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.

Cancer 2017 06 24;123(11):2025-2034. Epub 2017 Jan 24.

Center for International Blood and Marrow Transplantation (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30536DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445001PMC
June 2017

A Canine Model of Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2017 Mar 21;23(3):420-427. Epub 2016 Dec 21.

Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304921PMC
March 2017

A new standard for HIV-associated lymphoma.

Authors:
Andrew R Rezvani

Blood 2016 08;128(8):1026-7

STANFORD UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-06-723890DOI Listing
August 2016

Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Curr Hematol Malig Rep 2016 Feb;11(1):19-28

Department of Medicine, Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0302-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996265PMC
February 2016

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Biol Blood Marrow Transplant 2015 Feb 1;21(2):281-7. Epub 2014 Nov 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408880PMC
February 2015

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2015 Jan 30;21(1):105-12. Epub 2014 Sep 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Oncology, University of Washington, School of Medicine, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140060
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.09.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286386PMC
January 2015

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes.

Curr Opin Hematol 2013 Nov;20(6):509-14

Transplantation Biology Program, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328365a151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112741PMC
November 2013

Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.

Biol Blood Marrow Transplant 2013 Jul 10;19(7):1033-9. Epub 2013 Apr 10.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898851PMC
July 2013

Prevention of graft-vs.-host disease.

Expert Opin Pharmacother 2012 Aug 7;13(12):1737-50. Epub 2012 Jul 7.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N., D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2012.703652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509175PMC
August 2012

Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

Biol Blood Marrow Transplant 2012 Feb 4;18(2):265-72. Epub 2011 Jul 4.

Seattle Cancer Care Alliance Pharmacokinetics Laboratory, 825 Eastlake Ave. E, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733484PMC
February 2012

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2011 Nov 30;17(11):1594-601. Epub 2011 Jul 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center and University of Washington Medical Center, 1100Fairview Ave. N, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203323PMC
November 2011

Rituximab resistance.

Best Pract Res Clin Haematol 2011 Jun 13;24(2):203-16. Epub 2011 Apr 13.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2011.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113665PMC
June 2011

Allogeneic hematopoietic cell transplantation: the state of the art.

Expert Rev Hematol 2010 Jun;3(3):285-99

Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.10.21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943393PMC
June 2010

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2008 Dec;14(12):1380-4

Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810860PMC
December 2008

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation.

J Autoimmun 2008 May 31;30(3):172-9. Epub 2008 Jan 31.

Transplantation Biology Program, Fred Hutchinson Cancer Research Center and University of Washington, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2007.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2329571PMC
May 2008

Using allogeneic stem cell/T-cell grafts to cure hematologic malignancies.

Expert Opin Biol Ther 2008 Feb;8(2):161-79

Senior Fellow Fred Hutchinson Cancer Research Center & University of Washington, Transplantation Biology, Clinical Research Division, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.8.2.161 DOI Listing
February 2008